These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33538673)
41. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles. Sun Q; Li W; Li H; Wang X; Wang Y; Niu X Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726 [TBL] [Abstract][Full Text] [Related]
42. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting. Patel P; Raval M; Airao V; Bhatt V; Shah P J Microencapsul; 2022 Jan; 39(1):1-24. PubMed ID: 34825627 [TBL] [Abstract][Full Text] [Related]
43. Solid lipid nanoparticles for phytosterols delivery: The acyl chain number of the glyceride matrix affects the arrangement, stability, and release. Guo SJ; Ma CG; Hu YY; Bai G; Song ZJ; Cao XQ Food Chem; 2022 Nov; 394():133412. PubMed ID: 35728468 [TBL] [Abstract][Full Text] [Related]
44. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology. Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758 [TBL] [Abstract][Full Text] [Related]
45. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Dudhipala N; Veerabrahma K Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370 [TBL] [Abstract][Full Text] [Related]
47. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Liu J; Gong T; Wang C; Zhong Z; Zhang Z Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627 [TBL] [Abstract][Full Text] [Related]
49. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. Li S; Ji Z; Zou M; Nie X; Shi Y; Cheng G AAPS PharmSciTech; 2011 Sep; 12(3):1011-8. PubMed ID: 21811889 [TBL] [Abstract][Full Text] [Related]
50. Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles. Shiva G; Somaye M; Reza JM Acta Pharm; 2012 Dec; 62(4):547-62. PubMed ID: 23333889 [TBL] [Abstract][Full Text] [Related]
51. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against Adekiya TA; Kumar P; Kondiah PPD; Ubanako P; Choonara YE Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012770 [TBL] [Abstract][Full Text] [Related]
52. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
53. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287 [TBL] [Abstract][Full Text] [Related]
54. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization. Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427 [TBL] [Abstract][Full Text] [Related]
55. Preparation, optimization, and Nasiri F; Faghfouri L; Hamidi M Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713 [No Abstract] [Full Text] [Related]
56. Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations. Daneshmand S; Jaafari MR; Movaffagh J; Malaekeh-Nikouei B; Iranshahi M; Seyedian Moghaddam A; Tayarani Najaran Z; Golmohammadzadeh S Colloids Surf B Biointerfaces; 2018 Apr; 164():332-339. PubMed ID: 29413613 [TBL] [Abstract][Full Text] [Related]
57. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Kalhapure RS; Mocktar C; Sikwal DR; Sonawane SJ; Kathiravan MK; Skelton A; Govender T Colloids Surf B Biointerfaces; 2014 May; 117():303-11. PubMed ID: 24667076 [TBL] [Abstract][Full Text] [Related]
58. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis. Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137 [TBL] [Abstract][Full Text] [Related]
60. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]